DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Consumer Services
Author Program NEWCreate Narrative
CVSA logo

Covista Inc. Stock Price

NYSE:CVSA Community·US$4.2b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 29 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

CVSA Share Price Performance

US$0
-138.60 (-100.00%)
​
US$159.50
Fair Value
US$0
-138.60 (-100.00%)
​
Price US$0
Tue, 11 Aug 26
Fair ValueUS$159.50
Share Pricen/a

CVSA Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$159.5 21.6% undervalued intrinsic discount

Health Care Workforce Shortages And Digital Learning Will Support This Bullish Long Term Thesis

0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value US$140 10.7% undervalued intrinsic discount

Health Care Workforce Shortages Will Pressure Capacity Expansion Yet Support Long Term Potential

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value US$175 28.5% undervalued intrinsic discount

Health Care Workforce Shortages And Flexible Learning Will Support Stronger Long Term Outcomes

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
CVSA logo
Covista
21.6% undervalued intrinsic discount

Health Care Workforce Shortages And Digital Learning Will Support This Bullish Long Term Thesis

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 11 Aug
Read Narrative
CVSA logo
Covista
10.7% undervalued intrinsic discount

Health Care Workforce Shortages Will Pressure Capacity Expansion Yet Support Long Term Potential

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 26 Jun
Read Narrative
CVSA logo
Covista
28.5% undervalued intrinsic discount

Health Care Workforce Shortages And Flexible Learning Will Support Stronger Long Term Outcomes

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Published 24 Mar
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystConsensusTarget
CVSA logo

CVSA: Leadership Expansion And Healthcare Education Demand Will Drive Future Upside

Fair Value: US$159.5 21.6% undervalued intrinsic discount
3 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystLowTarget
CVSA logo

CVSA: Student Enrollment Momentum And Campus Expansion Will Support Future Upside

Fair Value: US$140 10.7% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
CVSA logo

Health Care Workforce Shortages And Flexible Learning Will Support Stronger Long Term Outcomes

Fair Value: US$175 28.5% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Excellent balance sheet and good value.

1 Risk
4 Rewards
View Full Analysis

Covista Inc. Key Details

US$2.0b

Revenue

US$833.7m

Cost of Revenue

US$1.1b

Gross Profit

US$853.1m

Other Expenses

US$267.4m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
7.86
57.34%
13.68%
45.8%
View Full Analysis

About CVSA

Founded
1987
Employees
4754
CEO
Stephen Beard
WebsiteView website
www.covista.com

Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary. The company provides degree programs, including bachelor’s, master’s, and doctoral degrees; and online certificate programs for nursing, health professions, medical, and veterinary postsecondary education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. It also operates Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company was formerly known as Adtalem Global Education Inc. and changed its name to Covista Inc. in February 2026. Covista Inc. was incorporated in 1987 and is headquartered in Chicago, Illinois.

Recent CVSA News & Updates

User avatar
Narrative Update • Aug 11

CVSA: Leadership Expansion And Healthcare Education Demand Will Drive Future Upside

Covista's analyst price target has shifted from $153.25 to $159.50, with analysts pointing to the recent fiscal Q4 results and their view that demand for healthcare professionals will continue to outpace supply as key supports for the updated valuation inputs. What’s in the News for Covista Covista expanded its leadership structure with an enlarged role for Scott Liles, who now leads corporate strategy and a new Performance Acceleration Office while continuing as President of the Medical and Veterinary segment.

Recent updates

No updates

Covista Inc. Competitors

TCOM logo

Trip.com Group

Symbol: NasdaqGS:TCOM
Market cap: US$24.4b
DRI logo

Darden Restaurants

Symbol: NYSE:DRI
Market cap: US$23.6b
FLUT logo

Flutter Entertainment

Symbol: NYSE:FLUT
Market cap: US$17.1b
H logo

Hyatt Hotels

Symbol: NYSE:H
Market cap: US$15.2b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide